Grandeur Pharma Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 15-06-2024
- Paid Up Capital ₹ 7.50 M
as on 15-06-2024
- Company Age 11 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 3.51 Cr
as on 15-06-2024
- Revenue 18.56%
(FY 2023)
- Profit 23.36%
(FY 2023)
- Ebitda -55.58%
(FY 2023)
- Net Worth 23.00%
(FY 2023)
- Total Assets 27.50%
(FY 2023)
About Grandeur Pharma
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 7.50 M.
The company currently has active open charges totaling ₹3.51 Cr.
Kushagra Ramchandani and Dhairya Ramchandani serve as directors at the Company.
- CIN/LLPIN
U24239DL2013PTC249057
- Company No.
249057
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
05 Mar 2013
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
New Delhi, Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Grandeur Pharma Private Limited offer?
Grandeur Pharma Private Limited offers a wide range of products and services, including Pain Relief Drugs & Pharmaceuticals, Arthritic Drugs, Digestive System Drugs & Medicines, Antacid Drugs, Anti Infective Drugs & Medicines, Antibiotic Injection, Common Disease Medicines, Antihistamines, Brain & Nervous System Drugs, Antiepileptic Drugs.
Who are the key members and board of directors at Grandeur Pharma?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kushagra Ramchandani  | Director | 02-Nov-2016 | Current |
| Dhairya Ramchandani | Director | 05-Mar-2013 | Current |
Financial Performance of Grandeur Pharma.
Grandeur Pharma Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 18.56% increase. The company also saw a substantial improvement in profitability, with a 23.36% increase in profit. The company's net worth Soared by an impressive increase of 23%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Grandeur Pharma?
In 2023, Grandeur Pharma had a promoter holding of 81.00% and a public holding of 19.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Madhav Nirman Private LimitedActive 19 years 11 monthsKushagra Ramchandani and Dhairya Ramchandani are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 06 Jul 2020 | ₹4.80 M | Open |
Others Creation Date: 27 Apr 2020 | ₹2.75 M | Open |
Others Creation Date: 10 Oct 2017 | ₹2.75 Cr | Open |
How Many Employees Work at Grandeur Pharma?
Unlock and access historical data on people associated with Grandeur Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Grandeur Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Grandeur Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
